BR112022015826A2 - Composições de ginsenosídeo - Google Patents

Composições de ginsenosídeo

Info

Publication number
BR112022015826A2
BR112022015826A2 BR112022015826A BR112022015826A BR112022015826A2 BR 112022015826 A2 BR112022015826 A2 BR 112022015826A2 BR 112022015826 A BR112022015826 A BR 112022015826A BR 112022015826 A BR112022015826 A BR 112022015826A BR 112022015826 A2 BR112022015826 A2 BR 112022015826A2
Authority
BR
Brazil
Prior art keywords
ginsenesiide
compositions
intestinal microbiota
ginsenosides
regulate
Prior art date
Application number
BR112022015826A
Other languages
English (en)
Portuguese (pt)
Inventor
Lecozannet Romain
Elizabeth Renée Fança-Berthon Pascale
Original Assignee
Givaudan Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB2004121.6A external-priority patent/GB202004121D0/en
Priority claimed from GBGB2005288.2A external-priority patent/GB202005288D0/en
Application filed by Givaudan Sa filed Critical Givaudan Sa
Publication of BR112022015826A2 publication Critical patent/BR112022015826A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
    • A61K36/258—Panax (ginseng)
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105—Plant extracts, their artificial duplicates or their derivatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
    • A61K31/704—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin attached to a condensed carbocyclic ring system, e.g. sennosides, thiocolchicosides, escin, daunorubicin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Mycology (AREA)
  • Botany (AREA)
  • Epidemiology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Food Science & Technology (AREA)
  • Nutrition Science (AREA)
  • Polymers & Plastics (AREA)
  • Psychiatry (AREA)
  • Anesthesiology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Pulmonology (AREA)
  • Hospice & Palliative Care (AREA)
  • Communicable Diseases (AREA)
  • Immunology (AREA)
  • Oncology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
BR112022015826A 2020-03-20 2021-03-17 Composições de ginsenosídeo BR112022015826A2 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB2004121.6A GB202004121D0 (en) 2020-03-20 2020-03-20 Improved compositions
GBGB2005288.2A GB202005288D0 (en) 2020-04-09 2020-04-09 Improved compositions
PCT/EP2021/056803 WO2021185897A1 (en) 2020-03-20 2021-03-17 Ginsenoside compositions

Publications (1)

Publication Number Publication Date
BR112022015826A2 true BR112022015826A2 (pt) 2022-10-04

Family

ID=75108332

Family Applications (2)

Application Number Title Priority Date Filing Date
BR112022015826A BR112022015826A2 (pt) 2020-03-20 2021-03-17 Composições de ginsenosídeo
BR112022016241A BR112022016241A2 (pt) 2020-03-20 2021-03-17 Composições de ginsenosídeo

Family Applications After (1)

Application Number Title Priority Date Filing Date
BR112022016241A BR112022016241A2 (pt) 2020-03-20 2021-03-17 Composições de ginsenosídeo

Country Status (8)

Country Link
US (2) US20230124503A1 (https=)
EP (2) EP4121061A1 (https=)
JP (2) JP7850670B2 (https=)
CN (2) CN115315266A (https=)
AU (2) AU2021238639A1 (https=)
BR (2) BR112022015826A2 (https=)
CA (2) CA3174699A1 (https=)
WO (2) WO2021185890A1 (https=)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2021185890A1 (en) * 2020-03-20 2021-09-23 Givaudan Sa Ginsenoside compositions
CN117224553B (zh) * 2023-11-02 2025-08-12 浙江大学 人参皂苷Rg3在制备治疗或预防肠道病毒感染的药物中的应用
CN117752706B (zh) * 2023-12-20 2025-10-14 浙江天皇药业有限公司 西洋参炮制品在制备治疗甲状腺功能减退症药物中的应用
WO2025261873A1 (en) 2024-06-20 2025-12-26 Givaudan Sa Improvements in or relating to compounds

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040202731A1 (en) * 2003-04-08 2004-10-14 Gow Robert T. Rosmarinic acid composition
US9956241B2 (en) * 2009-05-04 2018-05-01 Naturex, S.A. Application of American Ginseng to enhance neurocognitive function
US20100278944A1 (en) 2009-05-04 2010-11-04 Naturex, S.A. Application of american ginseng to enhance neurocognitive function
US10456436B2 (en) * 2013-11-04 2019-10-29 Wen Luan Wendy Hsiao Use of herbal saponins to regulate gut microflora
JP7223754B2 (ja) 2017-07-18 2023-02-16 セネッセンス ライフ サイエンセズ プライベート リミテッド 認知機能の低下の治療および予防、また神経機能の保持に関する組成物およびその方法。
CN110613802A (zh) 2018-06-20 2019-12-27 珠海岐微生物科技有限公司 白茅根大黄炭三七组合物及其在调节肠道微生物中的用途
CN109432304A (zh) * 2018-12-03 2019-03-08 杭州胡庆余堂药业有限公司 一种含铁皮石斛组合物在药物制备中的应用
WO2021185890A1 (en) 2020-03-20 2021-09-23 Givaudan Sa Ginsenoside compositions

Also Published As

Publication number Publication date
CA3174698A1 (en) 2021-09-23
US20230129389A1 (en) 2023-04-27
CN115315264A (zh) 2022-11-08
JP7808042B2 (ja) 2026-01-28
BR112022016241A2 (pt) 2022-10-11
US20230124503A1 (en) 2023-04-20
AU2021238639A1 (en) 2022-09-15
EP4121061A1 (en) 2023-01-25
EP4121076A1 (en) 2023-01-25
WO2021185890A1 (en) 2021-09-23
AU2021238643A1 (en) 2022-10-20
JP2023518064A (ja) 2023-04-27
WO2021185897A1 (en) 2021-09-23
JP7850670B2 (ja) 2026-04-23
JP2023519189A (ja) 2023-05-10
CA3174699A1 (en) 2021-09-23
CN115315266A (zh) 2022-11-08

Similar Documents

Publication Publication Date Title
BR112022015826A2 (pt) Composições de ginsenosídeo
CR20130584A (es) Cosmètico
BR112022022587A2 (pt) Composição encapsulada compreendendo microcápsulas do tipo núcleo-invólucro e processo para a sua preparação
MX2020013064A (es) Lactobacillus plantarum para el cuidado de la piel.
ZA202304795B (en) Minimal saponin analogues, synthesis and use thereof
BR112021021514A2 (pt) Cepas bacterianas probióticas que produzem ácidos graxos de cadeia curta e composições compreendendo as mesmas
MX351174B (es) Microorganismos que producen acido eicosapentaenoico, composiciones de acidos grasos,y metodos para prepararlos y usos de los mismos.
BR112014013098A2 (pt) composições compreendendo ácidos graxos que têm 20 carbonos e métodos de produção e uso dos mesmos
BR112019003247A2 (pt) ésteres de poliglicerol reticulados, seu método de preparo e uso e preparações cosméticas ou farmacêuticas
MX391171B (es) Anticuerpos anti-cd19 humano con alta afinidad
BR112018009885A2 (pt) produção de derivados de olefina graxos através de metátese de olefina
CO6541621A2 (es) Anticuerpos que se unen preferencialmente al dominio 4 extracelular de csf 1r humano y uso de los mismos
MX2013004616A (es) Aminas grasas, amidoaminas, y sus derivados de la metatesis de aceite natural.
BR112016006934A2 (pt) composição para prevenção da enterite necrótica em galloanserae
BR112022012577A2 (pt) Cepa de streptococcus thermophilus, composição, método para a preparação de um produto alimentício fermentado, método de obtenção de uma cepa e uso de uma cepa
ECSP18034035A (es) Compuestos de criptoficina novedosos y productos conjugados, su preparación y su uso terapéutico
BR112017022209A2 (pt) composição aquosa que compreende éster de ácido omega- aminocarboxílico e álcool graxo e seu uso
BR112015023726A2 (pt) gordura de reduzido teor de gordura; processo para a preparação de uma gordura de reduzido teor de gordura; processo para a preparação de um produto de panificação, confeitaria e/ou pastelaria vienense; e uso de uma gordura de reduzido teor de gordura
BR112021001188A8 (pt) Composição que contém vacina contra a influenza
BR112016001281B1 (pt) método de preparação de alquil éster de ácido graxo utilizando gordura
BR112020019053B8 (pt) Microalgas, método de produção de uma biomassa, e, método de produção de um bio-óleo
CL2021002652A1 (es) Método para mejorar la liberación de tejidos en lámina estructurada haciendo aplicaciones
BR112019007073A2 (pt) extrato de planta embebido em alulose e método de preparação
PL3809858T3 (pl) Kompozycje wielonienasyconych kwasów tłuszczowych wzbogacone w dha
BR112022001913A2 (pt) Métodos e composições para cultivar bactérias dependentes de hemoglobina